Immunology
-
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
This article has 23 authors:Reviewed by ScreenIT
-
Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice
This article has 15 authors:Reviewed by ScreenIT
-
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
This article has 6 authors:Reviewed by ScreenIT
-
Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate
This article has 21 authors:Reviewed by ScreenIT
-
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
This article has 48 authors:Reviewed by ScreenIT
-
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
This article has 32 authors:Reviewed by ScreenIT
-
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies
This article has 18 authors:Reviewed by ScreenIT
-
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
This article has 23 authors:Reviewed by ScreenIT
-
Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection
This article has 9 authors:Reviewed by ScreenIT
-
Optimised non-coding regions of mRNA SARS-CoV-2 vaccine CV2CoV improves homogeneous and heterogenous neutralising antibody responses
This article has 8 authors:Reviewed by ScreenIT